General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 331: Which of the following conditions demonstrates autosomal dominant inheritance?

A. Marfan syndrome (Correct Answer)
B. Sickle cell anaemia
C. Thalassemia
D. Hereditary spherocytosis

Explanation: **Explanation:** **Marfan Syndrome (Correct Answer):** Marfan syndrome is a classic example of an **autosomal dominant (AD)** disorder [1]. It is caused by a mutation in the **FBN1 gene** on chromosome 15, which encodes **Fibrillin-1**, a glycoprotein essential for the structural integrity of the extracellular matrix and the regulation of TGF-β signaling [1]. Because it is AD, the presence of a single mutated allele is sufficient to cause the disease, often showing high penetrance but variable expressivity [3]. **Analysis of Incorrect Options:** * **Sickle cell anaemia (B) & Thalassemia (C):** Both are **autosomal recessive (AR)** hemoglobinopathies. Clinical manifestations typically occur only when an individual inherits two mutant alleles (homozygous) [3], [4]. * **Hereditary spherocytosis (D):** While the most common inheritance pattern for Hereditary Spherocytosis is **Autosomal Dominant** (approximately 75% of cases), in the context of standard medical examinations like NEET-PG, when forced to choose between Marfan and HS, Marfan is the "textbook" prototype for AD inheritance. *Note: If this were a multiple-choice question where "all of the above" wasn't an option, Marfan remains the most definitive answer, though HS is also technically AD in most cases.* **High-Yield Clinical Pearls for NEET-PG:** * **Marfan Syndrome:** Look for "Arachnodactyly," **Ectopia lentis** (upward dislocation), and **Aortic dissection** (most common cause of death) [1]. * **Mnemonic for AD disorders:** "Very Powerful DOMINANT Humans" (Von Willebrand, Polycystic kidney, Dystrophia myotonica, Osteogenesis imperfecta, Marfan, Intermittent porphyria, Noonan, Achondroplasia, Neurofibromatosis, Tuberous sclerosis). * **Key Concept:** AD disorders usually involve **structural proteins** (like Fibrillin), whereas AR disorders usually involve **enzymes** [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 153-154. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 57-58. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 53-54. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 598-599.

Question 332: The gene for Wilms' tumor is located on which chromosome?

A. Chromosome 1
B. Chromosome 10
C. Chromosome 11 (Correct Answer)
D. Chromosome 12

Explanation: **Explanation:** The correct answer is **Chromosome 11**. Wilms' tumor (nephroblastoma) is the most common primary renal tumor of childhood. Its pathogenesis is strongly linked to mutations in tumor suppressor genes located on chromosome 11 [1]. Specifically, the **WT1 gene** is located at **11p13**, and the **WT2 gene** is located at **11p15.5** [1]. These genes are crucial for normal renal and gonadal development; their loss or mutation leads to the development of nephrogenic rests, which are precursors to Wilms' tumor. **Analysis of Options:** * **Chromosome 1:** While abnormalities in 1q are often associated with a poorer prognosis in Wilms' tumor, the primary causative genes (WT1/WT2) are not located here. * **Chromosome 10:** Mutations on chromosome 10 are classically associated with the **PTEN gene** (Cowden syndrome) and the **RET proto-oncogene** (MEN 2A/2B and Medullary Thyroid Carcinoma). * **Chromosome 12:** This chromosome is associated with several soft tissue tumors (e.g., liposarcoma via MDM2 amplification) but is not the primary locus for Wilms' tumor. **High-Yield Clinical Pearls for NEET-PG:** * **WAGR Syndrome:** (Wilms' tumor, Aniridia, Genitourinary anomalies, and mental Retardation) is associated with a microdeletion at **11p13** (WT1) [1]. * **Denys-Drash Syndrome:** Associated with **WT1** mutations; characterized by gonadal dysgenesis and early-onset nephropathy [1]. * **Beckwith-Wiedemann Syndrome (BWS):** Associated with the **WT2** locus (**11p15.5**); characterized by macroglossia, organomegaly, and hemihypertrophy. * **Histology:** Look for the **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 487-488.

Question 333: Which of the following conditions has a higher risk of malignancy?

A. Leukoplakia
B. Erythroplakia (Correct Answer)
C. Dysplasia
D. Hyperplasia

Explanation: **Explanation:** The correct answer is **Erythroplakia**. In the context of oral premalignant lesions, the risk of malignant transformation is determined by the degree of cellular atypia and architectural changes present at the time of diagnosis [3]. **1. Why Erythroplakia is the correct answer:** Erythroplakia is defined as a red, velvety, circumscribed plaque that cannot be characterized clinically or pathologically as any other condition. It carries the **highest risk of malignant transformation** (over 50%, with some studies suggesting up to 90%). Histologically, almost all cases of erythroplakia show significant epithelial dysplasia, carcinoma in situ, or even invasive squamous cell carcinoma at the time of initial biopsy [3]. The red appearance is due to the marked thinning of the epithelium (atrophy) overlying a highly vascularized subepithelial connective tissue. **2. Analysis of Incorrect Options:** * **Leukoplakia:** While more common than erythroplakia, its transformation rate is significantly lower (approximately 1–5%) [1]. It is a clinical term for a white patch; most are benign hyperkeratotic lesions [1]. * **Dysplasia:** This is a histological term referring to disordered growth [2]. While dysplasia is a precursor to cancer, "Erythroplakia" is the clinical entity that most consistently harbors high-grade dysplasia or early malignancy. * **Hyperplasia:** This is a reversible increase in the number of cells [2]. It is a physiological or pathological response to a stimulus and, by itself, does not imply a high risk of malignancy unless accompanied by atypia [2]. **NEET-PG High-Yield Pearls:** * **Speckled Leukoplakia (Erythroleukoplakia):** A clinical variant with white spots on a red base; it has a higher risk than pure leukoplakia but lower than pure erythroplakia. * **Most common site:** The floor of the mouth, tongue, and soft palate are high-risk sites for malignant transformation. * **Rule of thumb:** "Red is more dangerous than white" in oral pathology. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 344-345. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 746-747. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 209-210.

Question 334: Metastatic calcification does not occur in which of the following locations?

A. Fundal glands of intestine (Correct Answer)
B. Renal tubules
C. Lungs alveoli
D. Blood vessels

Explanation: **Explanation:** Metastatic calcification occurs in normal tissues due to hypercalcemia (elevated serum calcium levels) [1]. It characteristically affects tissues that lose acid, creating a **local alkaline environment**, which predisposes them to calcium salt deposition [1]. **Why Option A is correct:** The correct answer is **Fundal glands of intestine** because this is a distractor. Metastatic calcification occurs in the **Gastric mucosa** (specifically the acid-secreting fundic glands of the **stomach**, not the intestine) [1]. The stomach mucosa secretes HCl, leaving the intracellular environment alkaline and prone to calcification. The intestine does not share this specific acid-base dynamic. **Analysis of Incorrect Options:** * **B. Renal tubules:** The kidneys excrete acid (H+ ions), making the tubular cells alkaline. This makes the kidney a primary site for metastatic calcification (nephrocalcinosis) [1], [4]. * **C. Lungs alveoli:** The lungs lose CO2 (an acid), creating an internal alkaline environment in the alveolar walls and pulmonary veins [1], [2]. * **D. Blood vessels:** Systemic arteries and pulmonary veins are common sites because they carry oxygenated blood with lower CO2 levels (relative alkalinity) [1]. **High-Yield NEET-PG Pearls:** 1. **Dystrophic vs. Metastatic:** Dystrophic calcification occurs in **dead/dying** tissue with **normal** serum calcium. Metastatic occurs in **living** tissue with **high** serum calcium [2]. 2. **Common Causes:** Hyperparathyroidism (most common), Vitamin D toxicity, Sarcoidosis, and Bone resorption (Multiple Myeloma) [3], [5]. 3. **Morphology:** Calcium salts appear as fine, white granules or clumps. On H&E stain, they are **basophilic** (blue-purple) [1]. 4. **Special Stain:** **Von Kossa stain** (turns calcium black) and **Alizarin Red S** (turns calcium orange-red). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 76-77. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 134-135. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 127-128. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 941-942. [5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 667-668.

Question 335: Microarray is defined as:

A. A study of multiple genes (Correct Answer)
B. A study of disease
C. A study of organisms
D. A study of blood groups

Explanation: ### Explanation **Correct Option: A. A study of multiple genes** **Microarray technology** (specifically DNA microarrays) is a high-throughput molecular technique used to analyze the **expression levels of thousands of genes simultaneously** [1] or to detect variations in a genome. It consists of a solid surface (usually a glass slide or silicon chip) onto which microscopic spots of DNA sequences (probes) are attached [1]. When a patient’s sample (target DNA/RNA) is applied, hybridization occurs, allowing researchers to determine which genes are "turned on" or "off" or to identify copy number variations (CNVs) [1]. In modern pathology, it is a cornerstone of **pharmacogenomics** and personalized medicine. **Why other options are incorrect:** * **B. A study of disease:** This is the broad definition of **Pathology** itself. While microarrays help study diseases at a molecular level, the term specifically refers to the genetic tool. * **C. A study of organisms:** This refers to **Biology** or **Microbiology**. While microarrays can be used to identify microbial species, the technology is defined by its ability to analyze genetic material, not the organism as a whole. * **D. A study of blood groups:** This is **Immunohematology**. Blood grouping is typically performed via agglutination assays or specific molecular typing, but "microarray" is not the definition of this field. **NEET-PG High-Yield Pearls:** * **Comparative Genomic Hybridization (CGH) Microarray:** The gold standard for detecting submicroscopic chromosomal imbalances (deletions/duplications) that are too small to be seen on a standard karyotype [1]. * **Expression Profiling:** Used in oncology (e.g., **Mammaprint** for breast cancer) to predict prognosis and treatment response by studying the mRNA expression of specific gene sets. * **SNP Microarray:** Used to detect Single Nucleotide Polymorphisms and "Loss of Heterozygosity" (LOH), which is crucial in cancer genetics [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 186-187.

Question 336: An example of a tumor suppressor gene is

A. myc
B. fos
C. ras
D. Rb (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. Rb (Retinoblastoma gene)**. **1. Why Rb is the correct answer:** The **Rb gene**, located on chromosome **13q14** [1], [4], is the "prototype" of tumor suppressor genes [1]. It acts as a critical "brake" on the cell cycle by regulating the **G1 to S phase transition** [1], [2]. In its hypophosphorylated (active) state, the Rb protein binds to the **E2F transcription factor**, preventing the cell from entering the S phase [2]. When the cell is ready to divide, Rb is phosphorylated by Cyclin D-CDK4/6 complexes, releasing E2F and allowing DNA replication [2]. Loss of both alleles (Knudson’s "two-hit" hypothesis) leads to uncontrolled cell proliferation, most notably in Retinoblastoma and Osteosarcoma [1], [4]. **2. Why the other options are incorrect:** * **A. myc:** This is a **proto-oncogene** (specifically a nuclear transcription factor) [3]. Overexpression is linked to Burkitt Lymphoma (c-myc), Neuroblastoma (n-myc), and Small Cell Carcinoma of the lung (l-myc). * **B. fos:** This is a **proto-oncogene** that, along with *jun*, forms the AP-1 transcription factor complex involved in cell proliferation and differentiation. * **C. ras:** This is the most common **proto-oncogene** mutated in human tumors. It encodes a GTP-binding protein involved in signal transduction. **3. High-Yield NEET-PG Pearls:** * **TP53:** The "Guardian of the Genome," located on chromosome 17p; the most commonly mutated gene in human cancer [4]. * **Two-Hit Hypothesis:** Applies to tumor suppressor genes (recessive at the cellular level) [1], [5], whereas proto-oncogenes require only a "one-hit" gain-of-function mutation (dominant). * **Quiescence vs. Senescence:** Rb-mediated cell cycle arrest can lead to temporary (quiescence) or permanent (senescence) exit from the cell cycle. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 300. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 300-301. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 297-298. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 227-228. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 298-300.

Question 337: Macrophages are converted to epithelioid cells by which cytokine?

A. IL-2
B. IFN-y (Correct Answer)
C. TNF-a
D. TGF-b

Explanation: **Explanation:** The conversion of macrophages into epithelioid cells is the hallmark of **granulomatous inflammation**. This process is primarily mediated by **Interferon-gamma (IFN-γ)** [1]. **Why IFN-γ is the correct answer:** In a Type IV hypersensitivity reaction, CD4+ T-cells (Th1 subset) encounter an antigen and secrete **IL-12**, which further stimulates T-cells to produce **IFN-γ**. IFN-γ is the most potent activator of macrophages [1], [2]. Under its influence, macrophages undergo morphological changes: they increase in size, develop abundant eosinophilic cytoplasm, and their nuclei become elongated (resembling epithelial cells), thus becoming **epithelioid cells** [1]. These cells can further fuse to form multinucleated giant cells (e.g., Langhans giant cells) [1]. **Analysis of Incorrect Options:** * **A. IL-2:** Primarily functions as a T-cell growth factor, promoting the proliferation of T-lymphocytes and NK cells [2]. * **C. TNF-α:** While TNF-α is crucial for the *maintenance* and physical integrity of a granuloma (by inducing adhesion molecules), it is not the primary cytokine responsible for the initial transformation of macrophages into epithelioid cells. * **D. TGF-β:** An anti-inflammatory cytokine involved in tissue repair and fibrosis; it generally inhibits macrophage activation. **High-Yield Clinical Pearls for NEET-PG:** * **Epithelioid cells** are charactersized by a lack of phagocytic activity but have increased secretory capacity. * **Granuloma Definition:** A microscopic aggregation of epithelioid cells surrounded by a collar of lymphocytes and plasma cells [1]. * **TNF-α Inhibitors:** Drugs like Infliximab can cause the "breakdown" of old granulomas, leading to the reactivation of latent Tuberculosis. * **Key Cytokine Sequence:** IL-12 (induces Th1) → IFN-γ (activates macrophages) → TNF-α (maintains granuloma). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 109. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 216-218.

Question 338: Genomic imprinting results in which of the following syndromes?

A. Ehlers-Danlos Syndrome
B. Turner Syndrome
C. Haw River syndrome
D. Angelman syndrome (Correct Answer)

Explanation: **Explanation:** **Genomic Imprinting** is an epigenetic process where certain genes are expressed in a parent-of-origin-specific manner [1]. While most genes are expressed from both alleles, imprinted genes are "silenced" (via methylation) in either the egg or the sperm [1]. **Why Angelman Syndrome is correct:** Angelman syndrome and Prader-Willi syndrome (PWS) are the classic examples of imprinting defects involving **Chromosome 15q11-q13** [1]. * **Angelman Syndrome ("Happy Puppet"):** Occurs due to the loss of the **maternal** allele (UBE3A gene), while the paternal allele is normally imprinted (silenced) [1]. * **Prader-Willi Syndrome:** Occurs due to the loss of the **paternal** allele, while the maternal allele is silenced [1]. **Why other options are incorrect:** * **A. Ehlers-Danlos Syndrome:** A group of connective tissue disorders caused by defects in the synthesis or structure of **fibrillar collagen**. It follows Mendelian inheritance (mostly Autosomal Dominant or Recessive). * **B. Turner Syndrome (45, XO):** A **chromosomal aneuploidy** caused by complete or partial monosomy of the X chromosome, usually due to nondisjunction during meiosis. * **C. Haw River Syndrome:** A rare neurodegenerative condition belonging to the group of **Trinucleotide Repeat Expansion** disorders (specifically CAG repeats), similar to Huntington’s disease. **High-Yield Clinical Pearls for NEET-PG:** * **Uniparental Disomy (UPD):** A common cause of imprinting disorders where an individual receives two copies of a chromosome from one parent and none from the other. * **Angelman Mnemonic:** **M**aternal deletion = **A**ngelman (**M**an). Clinical features include inappropriate laughter, seizures, ataxia, and severe intellectual disability [1]. * **Prader-Willi Mnemonic:** **P**aternal deletion = **P**rader-Willi. Clinical features include hyperphagia (obesity), hypogonadism, and hypotonia [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 181-183.

Question 339: What is the term for a primary structural defect of an organ?

A. Malformation (Correct Answer)
B. Disruption
C. Deformation
D. Association

Explanation: ### Explanation **1. Why Malformation is Correct:** A **Malformation** is a primary structural defect of an organ or body part resulting from an **intrinsically abnormal developmental process**. The error occurs at the genetic or embryological level during the period of organogenesis (typically weeks 3–8 of gestation) [1]. Because the "blueprint" itself is flawed, the organ never develops correctly. Examples include congenital heart defects, polydactyly, or cleft lip [2]. **2. Why the Other Options are Incorrect:** * **Disruption (Option B):** This is a secondary destruction of an organ or body part that was **initially developing normally**. It is caused by an extrinsic disturbance (e.g., amniotic bands causing limb amputation or vascular accidents). * **Deformation (Option C):** This refers to an abnormal shape or position of a body part caused by **mechanical forces** (extrinsic pressure) acting on a normal fetus over a prolonged period. A classic example is clubfoot (talipes) due to oligohydramnios (insufficient amniotic fluid). * **Association (Option D):** This is a non-random occurrence of a group of anomalies that occur together more frequently than expected by chance, but without a known common etiology. A high-yield example is **VACTERL** (Vertebral, Anal, Cardiac, Tracheo-Esophageal, Renal, and Limb anomalies). **3. NEET-PG High-Yield Pearls:** * **Sequence:** A single primary anomaly that leads to a cascade of secondary defects (e.g., **Potter Sequence**, where renal agenesis leads to oligohydramnios, which causes pulmonary hypoplasia and flattened facies). * **Syndrome:** A constellation of anomalies that are pathogenetically related (e.g., Down Syndrome) [2]. * **Agenesis:** Complete absence of an organ and its primordium. * **Aplasia:** Absence of an organ but the presence of a rudimentary primordium. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 463-464. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 92-93.

Question 340: Regeneration is the replacement of lost tissue by:

A. Surface epithelium
B. Granulation tissue
C. Living tissue of any kind
D. Living tissue of a similar kind (Correct Answer)

Explanation: **Explanation:** The core concept in tissue repair is the distinction between **Regeneration** and **Healing by Repair (Fibrosis)**. **Why Option D is Correct:** Regeneration is defined as the replacement of damaged or lost cells by cells of the **same type** (similar kind) [1]. This process restores the tissue to its original structural and functional state without scarring. It occurs primarily in tissues composed of **labile cells** (e.g., hematopoietic cells, surface epithelia) or **stable cells** (e.g., liver, kidney), provided the underlying connective tissue framework (basement membrane) remains intact [1]. **Why Other Options are Incorrect:** * **Option A (Surface epithelium):** While surface epithelium regenerates, regeneration is not limited to it. Internal organs like the liver also undergo regeneration (e.g., compensatory hyperplasia after partial hepatectomy) [2]. * **Option B (Granulation tissue):** This is the hallmark of **Repair/Healing**, not regeneration. Granulation tissue (composed of fibroblasts, new capillaries, and inflammatory cells) eventually leads to scar formation (fibrosis) when the tissue cannot regenerate [1]. * **Option C (Living tissue of any kind):** This is too broad. If a specialized cell (like a cardiac myocyte) is replaced by a different type of living tissue (like a fibroblast/scar), it is "Repair," not "Regeneration" [1]. **High-Yield NEET-PG Pearls:** 1. **Cell Types:** * **Labile:** Continuously dividing (Skin, GI mucosa) [3]. * **Stable:** Quiescent but can divide if injured (Liver, Kidney, Pancreas) [2]. * **Permanent:** Cannot divide; always heal by scarring (Neurons, Cardiac myocytes). 2. **The "Framework" Rule:** For perfect regeneration to occur in stable cells, the **extracellular matrix (ECM)** must be intact [1]. If the ECM is destroyed, healing occurs via fibrosis even in regenerative tissues. 3. **Key Growth Factor:** **TGF-β** is the most important cytokine for synthesis and deposition of connective tissue proteins (fibrosis). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 112-115. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 108-109. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 104-105.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free